Photopheresis therapy are being conducted to investigate its potential benefits in the treatment
As the autoimmune disease becomes more common around the world, researchers are doing everything they can to find the most effective cure. Photopheresis has emerged as a promising treatment option for autoimmune diseases, solid organ transplant rejection, chronic graft versus host disease, and advanced cutaneous T-cell lymphoma. Currently, a few clinical trials on photopheresis therapy are being conducted to investigate its potential benefits in the treatment of autoimmune disease conditions. Photopheresis therapy for the treatment of autoimmune diseases is still in its early stages. The amount of time and money required to complete the treatment is enormous. This factor may make the treatment less appealing to many patients and may compel healthcare practitioners to switch to other low-cost and less time-consuming treatments, limiting the global photopheresis product overall growth prospects. Mallinckrodt Pharmaceuticals is actively conducting clinical trials on novel ...